In an animal study, researchers observed an increase in LCN expression in the substantia nigra after injecting 6-hydroxydopamine into the medial forebrain bundle, indicating a potential association between elevated LCN2 levels and PD pathogenesis. The gene discussed is LCN2; the disease is Parkinson disease.